Category

Daily Briefs

Daily Brief Industrials: Firefly Aerospace and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Firefly Aerospace Inc. (FLY): Peeking at the IPO Prospectus of the Next Space & Defense Tech Company


Firefly Aerospace Inc. (FLY): Peeking at the IPO Prospectus of the Next Space & Defense Tech Company

By IPO Boutique

  • Their operational launch vehicle, Alpha, is the first and only U.S.-based orbital rocket in the 1,000 kilograms class to successfully reach orbit, with four launches completed successfully.
  • They had revenue of $55.23 million and $60.79 million and net loss of $135.46 million and $231.13 million in 2023 and 2024, respectively.
  • The company is targeting a potential IPO in the second half of July or early August with peers and the sector outperforming in the short term. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Overview #30 – the Summer Doldrums-Not! Stage setting for the next phase of the bull market. and more

By | Daily Briefs, Macro

In today’s briefing:

  • Overview #30 – the Summer Doldrums-Not! Stage setting for the next phase of the bull market.


Overview #30 – the Summer Doldrums-Not! Stage setting for the next phase of the bull market.

By Rikki Malik

  • A review of recent events/data impacting our investment themes and outlook
  • Tariff chatter is a sideshow; the real focus should be  on the US Administration’s Fed plans
  • Non-Chinese miners of rare earths and other strategic minerals will command a steep premium.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: NSDL, Mapletree Logistics Trust, ZEEKR and more

By | Daily Briefs, Financials

In today’s briefing:

  • NSDL Vs CDSL: A Bottom-Up Comparison
  • US-China Decoupling: The Reshaping of Asian Industrial Logistics  – SHORT MapleTree Logistics Trust
  • (Mostly) Asia-Pac M&A: ZEEKR, DD Group, Hanil Cement, Adriatic Metals, Abacus Storage, PointsBet


NSDL Vs CDSL: A Bottom-Up Comparison

By Himanshu Dugar

  • NSDL has been gearing up for its IPO and is very likely to hit the markets shortly within the SEBI stipulated deadline of 31st July.
  • NSDL historically had the upper hand over CDSL as institutional clients led to strong outperformance. But the booming retail investment landscape since 2021 has turned the tables on the leader.
  • Given that the trend of retail participation inching is expected to continue, NSDL needs to rejuvenate its approach to plough back market share. Payments banking business cant offset the impact.

US-China Decoupling: The Reshaping of Asian Industrial Logistics  – SHORT MapleTree Logistics Trust

By Jacob Cheng

  • The US-China decoupling is resulting in geo-political risks, causing structural changes to China’s manufacturing and logistics sector.  Companies re-locate their supply chains due to “China Plus One” strategy. 
  • Despite E-commerce remains as a long-term strong driver for China logistics, the sector is facing severe over-supply in the near term.  National vacancy is 20.3% at Q1 2025
  • We recommend SHORT MapleTree Logistics Trust, due to its significant exposure to China logistics.  DPU, NPI and ROE are on downward trend

(Mostly) Asia-Pac M&A: ZEEKR, DD Group, Hanil Cement, Adriatic Metals, Abacus Storage, PointsBet

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: The United Laboratories International Holdings Limited and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • China Healthcare Weekly(July20)-WuXi AppTec 25H1, Sino Biopharm Acquire LaNova, United Lab Placement


China Healthcare Weekly(July20)-WuXi AppTec 25H1, Sino Biopharm Acquire LaNova, United Lab Placement

By Xinyao (Criss) Wang

  • WuXi AppTec’s 25H1 Profit Alert indicates the whole year performance may beat expectations. However, “valuation discount” reflects geopolitical risks. The intensive share repurchases is insignificant compared with previous share reductions.
  • Sino Biopharm will pay US$500.9 million to acquire LaNova. Based on pipeline/licensing cooperation, this is a deal with very high cost performance. However, valuation contribution may remain to be seen.
  • United Lab plans to raise HK$2.17 billion in net proceeds from Placement. Valuation logic will shift from a traditional bulk medicine company to innovative drug company. 15x P/E is expected.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Dickson Concepts Intl, Seven & I Holdings, Tesla and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Dickson Concepts (113 HK): A Necessary HK Arbageddon
  • Weekly Deals Digest (20 Jul) – Seven & I, Shibaura, DD Group, Dickson, Abacus Storage, PointsBet
  • TSLA Q2 Earnings: Options Appear Complacent Vs. TSLA’s Volatile History
  • Last Week In Event SPACE: Seven & I, Krungthai Card, GMO Internet, Jardine Matheson


Dickson Concepts (113 HK): A Necessary HK Arbageddon

By Arun George

  • Dickson Concepts Intl (113 HK) shareholders have voted against Sir Poon’s HK$7.20 per share offer. The vote marginally failed the <10% of all disinterested shareholders’ rejection threshold.
  • While painful, this deal break was arguably the correct outcome as the offer was below the net cash and Dickson is cash generative on an underlying basis. 
  • Unlike the last HK deal break (Soundwill), the price action over the last two days indicated a done deal. My estimated break price is HK$5.00 (30% downside to last close).

Weekly Deals Digest (20 Jul) – Seven & I, Shibaura, DD Group, Dickson, Abacus Storage, PointsBet

By Arun George


TSLA Q2 Earnings: Options Appear Complacent Vs. TSLA’s Volatile History

By John Ley

  • TSLA is set to report Q2 earnings after the close on Wednesday, July 23, following a 28% rally since its last report.
  • We examine implied vol and the projected earnings-day move, which may be underpricing event risk.
  • Volatility positioning and historical earnings reactions are assessed to help frame expectations.

Last Week In Event SPACE: Seven & I, Krungthai Card, GMO Internet, Jardine Matheson

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Taishin Financial Holding, Lens Technology, Mazagon Dock Shipbuilders , Lg Innotek, Seven & I Holdings, Mitsui Matsushima, Ryohin Keikaku, Dickson Concepts Intl, LG Chem Ltd and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Taishin (2887 TT)/Shin Kong (2888 TT) Merger: Index Flows in July
  • Lens Technology (6613 HK): Offering Details & Index Inclusion
  • AMFI Stock Reclassification Preview (Jun 2025): Active Flows Lead to Passive Flows
  • KOSPI Size Indices: Overlaps Between Active & Passive Flows
  • 7&I (3382 JP) – Alimentation Couche-Tard Walks, Lobbing a Letter Bomb
  • [Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications
  • Ryohin Keikaku (7453 JP): Global Index Inclusion Likely in August
  • HEW: Inflation Persists, But Cuts Loom
  • Dickson Concepts (113 HK): A Necessary HK Arbageddon
  • Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (18 July to 1 August 2025)


Taishin (2887 TT)/Shin Kong (2888 TT) Merger: Index Flows in July

By Brian Freitas


Lens Technology (6613 HK): Offering Details & Index Inclusion

By Brian Freitas

  • Lens Technology (6613 HK)‘s global offering opened yesterday, and the raise could reach up to US$800m if the offer-size adjustment option and the overallotment option are exercised.
  • The allocation to cornerstone investors is smaller than in other recent AH listings. The discount of over 25% to the A-shares is attractive given the recent trend for large listings.
  • Lens Technology (6613 HK) could be added to a global index in December. Inclusion in Southbound Stock Connect in August and HSCI inclusion could take place in March 2026.

AMFI Stock Reclassification Preview (Jun 2025): Active Flows Lead to Passive Flows

By Brian Freitas

  • We forecast 10 stocks moving from MidCap to LargeCap, 11 stocks moving from LargeCap to MidCap, 10 stocks from SmallCap to MidCap, and 13 stocks from MidCap to SmallCap.
  • From the new listings, 1 stock is expected to be added to Large cap, 2 stocks are expected to be added to Mid Cap, and multiple stocks to Small Cap.
  • There are multiple stocks among the AMFI changes that will be changes for global indices, NIFTY Index, NSE Nifty Next 50 Index and/or Nifty Midcap 150 Index in September.

KOSPI Size Indices: Overlaps Between Active & Passive Flows

By Brian Freitas

  • The review period for the September rebalance of the KOSPI Size Indices commenced on 1 June and will end on 31 August.
  • Nearing halfway in the review period, we forecast 53 migrating stocks. Among new listings, 1 stock could be added to LargeCap, 3 to MidCap and 1 to SmallCap.
  • Two potential downward migrations could be deleted from a global index in August. The new listing that is a potential LargeCap add could be added to a globalindex in September.

7&I (3382 JP) – Alimentation Couche-Tard Walks, Lobbing a Letter Bomb

By Travis Lundy

  • Alimentation Couche-Tard (ATD CN) which proposed a takeover to Seven & I Holdings (3382 JP) almost a year ago, has walked. They delivered a letter bomb on the way out.
  • The letter is titled “ALIMENTATION COUCHE-TARD ANNOUNCES WITHDRAWAL OF PROPOSAL TO ACQUIRE SEVEN & I HOLDINGS DUE TO LACK OF ENGAGEMENT.” This is not the first time they have complained.
  • The letter is not aimed at the 7&i Board or at ATD stakeholders. It is meant to drive a wedge between 7&i active shareholders and its management team. We’ll see.

[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications

By Travis Lundy

  • Today, Mitsui Matsushima (1518 JP) announced the results of its Buyback Tender Offer to repurchase up to 3,999,999 shares (35.8% of shares out ex-Treasury) at ¥5,000/share. 
  • Murakami-San owned 42% of the voting rights at announcement, then bought more on the dip just below ¥5,000/share. 
  • The Tender Offer Buyback was “successful” in that it bought back 3.3mm shares. But the result was FAR more interesting than I expected. Surprising Results with Surprising Implications

Ryohin Keikaku (7453 JP): Global Index Inclusion Likely in August

By Brian Freitas

  • Ryohin Keikaku (7453 JP)‘s stock price has more than doubled this year and the increased market cap could now result in a global index inclusion.
  • Ryohin Keikaku (7453 JP) has outperformed its peers by a BIG margin since its inclusion in the Nikkei 225 (NKY INDEX) in September 2024.
  • There appears to be significant positioning in the stock. Given the huge outperformance over the last few months, trim into strength.

HEW: Inflation Persists, But Cuts Loom

By Phil Rush

  • Persistent upside inflation surprises and sticky wage growth are lifting hawkish market narratives, defying central bank and consensus hopes for a quick return to target.
  • UK inflation jumped well above forecast in June, strengthening the hawkish case, while US core inflation shows tariffs adding to excessive underlying price pressures.
  • Next week, attention turns to the ECB decision, July flash PMIs, and UK public finances, as markets weigh central banks’ willingness to ignore resurgent inflation.

Dickson Concepts (113 HK): A Necessary HK Arbageddon

By Arun George

  • Dickson Concepts Intl (113 HK) shareholders have voted against Sir Poon’s HK$7.20 per share offer. The vote marginally failed the <10% of all disinterested shareholders’ rejection threshold.
  • While painful, this deal break was arguably the correct outcome as the offer was below the net cash and Dickson is cash generative on an underlying basis. 
  • Unlike the last HK deal break (Soundwill), the price action over the last two days indicated a done deal. My estimated break price is HK$5.00 (30% downside to last close).

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (18 July to 1 August 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stock picks and key catalysts in the Korean stock market for the two weeks (18 July to 1 August 2025).
  • Our top 10 picks were up on average 4.5% in the past two weeks, slightly outperforming KOSPI which was up 4.4% in the same period.
  • The top 10 picks in this bi-weekly include Hanil Cement, LG CNS, KCC Corp, Poongsan, Paradise, Samsung Electronics, Naver, SM Entertainment, LG Chem, and SK Inc. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Australia: Cochlear Ltd, Next Science Ltd, Northern Star Resources, Mesoblast Ltd, Pro Medicus Ltd, Santos Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Cochlear Limited: Initiation of Coverage- Can Cutting-Edge Innovation & R&D Fuel the Next Growth Surge?
  • Next Science Asset Sale to Demetra Holdings: Potential 13% Upside with Capital Return and Strategic Acquisition
  • Northern Star Resources: Initiation of Coverage- Why Mining Stabilization at Super Pit Could Be a Game-Changer!
  • Mesoblast (MSB AU): Ryoncil Starts on a High Note- A Step Toward Profitable Growth
  • Pro Medicus: Initiation of Coverage- Breaking Barriers in U.S. Imaging with Next-Gen Expansion Strategy!
  • Santos Limited: Initiation of Coverage- Power Moves in Contracts, Decommissioning, & Growth!


Cochlear Limited: Initiation of Coverage- Can Cutting-Edge Innovation & R&D Fuel the Next Growth Surge?

By Baptista Research

  • Cochlear Limited recently announced its half-year results for fiscal year 2025.
  • In its earnings call, the company disclosed a mixed performance across its business segments.
  • On the positive side, the company reported a strong 13% growth in Cochlear implant revenue and an even stronger 22% growth in Acoustics revenue, leading to an overall net sales increase of 6% in constant currency.

Next Science Asset Sale to Demetra Holdings: Potential 13% Upside with Capital Return and Strategic Acquisition

By Special Situation Investments

  • Next Science plans to distribute net proceeds of US$30m from asset sale to shareholders, equating to A$0.158/share.
  • The asset sale requires shareholder approval, with major stakeholders like the Walker family likely supporting the transaction.
  • Uncertainties include FDA compliance issues, tax treatment of distribution, and potential changes in net proceeds estimate.

Northern Star Resources: Initiation of Coverage- Why Mining Stabilization at Super Pit Could Be a Game-Changer!

By Baptista Research

  • Northern Star Resources Ltd’s March 2025 quarterly results showcased a strong financial and operational performance, despite facing some operational challenges.
  • The company generated robust net mine cash flow of $295 million, with positive contributions from all production centers.
  • The gold price, exceeding AUD 5,000 per ounce, aided this financial strength, alongside the company’s low-risk mining jurisdictions in Western Australia and Alaska.

Mesoblast (MSB AU): Ryoncil Starts on a High Note- A Step Toward Profitable Growth

By Tina Banerjee

  • Mesoblast Ltd (MSB AU) reported $13.2M revenue from Ryoncil since its launch on March 28 through June 30. With full treatment cost of $1.55M, Ryoncil pricing has been reasonably set.
  • With mandatory CMS coverage becoming effective on July 1 in all U.S. states and Mesoblast completing onboarding of the remaining major U.S. transplant centers, Ryoncil revenue is expected to accelerate.
  • As of June 30, 2025, Mesoblast had cash balance of $162M. Considering cash burn of $16.6M for the latest quarter, the company has an estimated funding available for ~10 quarters.

Pro Medicus: Initiation of Coverage- Breaking Barriers in U.S. Imaging with Next-Gen Expansion Strategy!

By Baptista Research

  • Pro Medicus Limited, a healthcare IT company specializing in enterprise imaging, reported a record first half of the fiscal year in both financial performance and strategic milestones.
  • The company’s revenue increased by 31.1%, with profit after tax soaring by 42.7%, reflecting robust financial health.
  • The earnings before interest and taxes (EBIT) margin grew to 71.9%, underscoring the company’s profitability.

Santos Limited: Initiation of Coverage- Power Moves in Contracts, Decommissioning, & Growth!

By Baptista Research

  • Santos Limited reported its 2024 full-year financial and operational results, presenting a detailed picture of the company’s current status, achievements, and challenges.
  • The company highlighted a strong financial performance supported by disciplined cost controls, robust revenues, and significant strategic projects either completed or progressing as scheduled.
  • On the positive side, Santos reported sales revenue of $5.4 billion, which translated into $3.7 billion in EBITDAX and $1.2 billion in profit after tax.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Douzone Bizon, Hanil Cement Co Ltd/New and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Douzone Bizon: First Real Test for Korea’s De Facto Mandatory Tender?
  • Clearing a Common Misconception — No Pre-Cover Needed in Hanil Stock-For-Stock Swap


Douzone Bizon: First Real Test for Korea’s De Facto Mandatory Tender?

By Sanghyun Park

  • Founder Kim reportedly looking to offload his 21.5% stake, with EQT eyeing a ~30% control block including Shinhan’s. No succession plans, deal said to be under serious review.
  • Kim’s control premium ask could trigger Korea’s first test case of expanded fiduciary duty, with minority holders potentially suing if tender terms aren’t seen as fair under new rules.
  • Buyer likely prepping a Q3 tender offer; key watch is how minority premium stacks vs control block — could be Korea’s first de facto test case of mandatory tender mechanics.

Clearing a Common Misconception — No Pre-Cover Needed in Hanil Stock-For-Stock Swap

By Sanghyun Park

  • Some still think we must close the borrow pre-settlement in a stock-for-stock merger. But KSD handles it fine — no need to pre-cover if shares stay lendable post-swap.
  • Spread flipped negative — rare setup in Korea. Tight float on both sides (insider-heavy) is killing liquidity and borrow, leading to this reverse arb play.
  • Deal break risk is minimal, new share listing is relatively soon, and the negative spread may widen—making this a compelling setup for a reverse arb play.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Samsonite, Alphabet , USD Coin, James Hardie Industries , Agilent Technologies, Apple , Crude Oil, Shoulder Innovations, Zephyr Energy and more

By | Daily Briefs, United States

In today’s briefing:

  • Samsonite (1910 HK): Trading Cheap, Yet Tariffs Loom. And Shorts At All-Time High
  • GOOGL: Q2 Vol Pricing, Performance Trends, and Earnings Setup
  • Singapore Emerges as the Stablecoin Safehouse
  • James Hardie Industries: Initiation of Coverage- $625 Million Synergy Blueprint Set to Reshape Industry Dynamics!
  • Agilent: Back To The Lab – [Business Breakdowns, EP.223]
  • Smartphone 2Q25: Boring Boring
  • [ETP 2025/29] Chevron Secures Guyana Win as SLB Surprises; WTI Slips, Henry Hub Snaps Losing Streak
  • Shoulder Innovations, Inc. (SI): Peeking at the Prospectus of Another MedTech IPO
  • Zephyr Energy Plc (AIM: ZPHR): Refining the path to first production in the Paradox. About to start drilling in the Rockies


Samsonite (1910 HK): Trading Cheap, Yet Tariffs Loom. And Shorts At All-Time High

By David Blennerhassett

  • Samsonite (1910 HK), the world’s leading travel luggage manufacturer/retailer, is trading well below its historical metrics. 
  • The share price is up ~30% from its recent low, but down ~22% YTD following a ~31% fall over a 10-day period in early-April, shortly after Trump’s “Liberation Day” speech. 
  • Management initiated a US$200mn buyback program last August. Overhangs include tariff and weak retail market in Asia and North America. Plus short selling has touched an all-time high.

GOOGL: Q2 Vol Pricing, Performance Trends, and Earnings Setup

By John Ley

  • GOOGL is set to release Q2 earnings on Wednesday, July 23 after the close, having rallied 15.39% since Q1 results.
  • Q2 has historically delivered strong average returns and the largest average absolute 1-day move.
  • We explore how volatility and past earnings reactions frame expectations for the upcoming release.

Singapore Emerges as the Stablecoin Safehouse

By GEMS Research – Aletheia Capital

  • Singapore has emerged as one of the earliest jurisdictions to establish a comprehensive regulatory regime for fiat-referenced stablecoins.
  • The Monetary Authority of Singapore (MAS) has adopted the Single-Currency Stablecoin (SCS) Framework.
  • The adoption is mainly in institutional trials and crypto-native payment flows, but the potential is immense.

James Hardie Industries: Initiation of Coverage- $625 Million Synergy Blueprint Set to Reshape Industry Dynamics!

By Baptista Research

  • James Hardie Industries Plc demonstrated a mixed performance in its fiscal fourth quarter of 2025, underpinned by its strategic growth initiatives amidst challenging market conditions.
  • Despite facing a softer demand environment and macroeconomic uncertainties, the company managed to achieve its financial targets, indicative of its strategic agility and operational discipline.
  • On the positive side, James Hardie’s focus on strategic investments and scaling the organization has borne fruit.

Agilent: Back To The Lab – [Business Breakdowns, EP.223]

By Business Breakdowns

  • Agilent is a leading provider of instruments, services, and consumables for labs in the life sciences, diagnostics, applied chemical markets, and R&D sectors
  • With a market cap of $30 billion, Agilent was born within Hewlett Packard and spun off more than 25 years ago
  • Agilent has a total addressable market of $160 billion and has a history dating back to 1938, starting as a testing instrument for audio equipment used by Disney in the production of Fantasia

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Smartphone 2Q25: Boring Boring

By Nicolas Baratte

  • IDC and Counterpoint released their 2Q25 smartphone estimates. Smartphone units increased 1-2% YoY. Best performer: Samsung +8% YoY, but this didn’t help 2Q operating profits. Vivo +5%, Apple +2%.
  • The smartphone market is desperately flat – or in slow decline. Smartphone is 76% of revenues for Qualcomm, 57% for Mediatek, 50% Apple and Xiaomi, 35% Samsung, 31% TSMC. Problem?
  • For Semiconductor firms (QCOM, MTK, TSM), chips ASP increases 10-15% at each generation, between node migration (N3, N2) and increasing AI functionalities. For hardware vendors (Apple, Samsung, Xiaomi), it’s worse.

[ETP 2025/29] Chevron Secures Guyana Win as SLB Surprises; WTI Slips, Henry Hub Snaps Losing Streak

By Suhas Reddy

  • Chevron’s arbitration win over ExxonMobil unlocks Guyana’s Stabroek Block, a key asset underpinning its USD 53 billion Hess acquisition.
  • SLB outperformed Q2 estimates despite YoY declines and also completed its ChampionX acquisition amid regulatory challenges.
  • WTI crude found support late-week after better-than-expected economic data tempered demand fears, despite early pressure from inventory and macro concerns.

Shoulder Innovations, Inc. (SI): Peeking at the Prospectus of Another MedTech IPO

By IPO Boutique

  • They are a commercial stage medical technology company that currently offers advanced implant systems for shoulder arthroplasty.
  • They generated net revenue of $31.6 million for the year ended December 31, 2024, compared to net revenue of $19.3 million for the year ended December 31, 2023 (64% growth).
  • This IPO could set terms as early as next week for a late July or early August debut. 

Zephyr Energy Plc (AIM: ZPHR): Refining the path to first production in the Paradox. About to start drilling in the Rockies

By Auctus Advisors

  • • The Paradox initial processing capacity is envisaged to be able to handle 5-10 mmcf/d.
  • Our base case assumes a conservative 5 mmcf/d, although throughput capacity is expected to increase with the tie-in of additional wells, including 16-2LN-CC and 28-11.
  • Notably, the plant’s initial capacity is below the production potential of the 36-2R well.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Anthem Biosciences and more

By | Daily Briefs, India

In today’s briefing:

  • Anthem Biosciences IPO Trading – Robust Insti Coverage Drives Overall Demand


Anthem Biosciences IPO Trading – Robust Insti Coverage Drives Overall Demand

By Akshat Shah

  • Anthem Biosciences (1234D IN) raised about US$397m in its India IPO.
  • Anthem Biosciences (ABS) is a contract research, development and manufacturing organisation (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.
  • We have looked at the company’s past performance in our previous notes. In this note, we will talk about the peer comp and IPO valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars